{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T01:01:22Z","timestamp":1778115682028,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T00:00:00Z","timestamp":1435017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ijid.2015.06.011","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T21:40:06Z","timestamp":1435182006000},"page":"86-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparison of susceptibility of HIV-1 variants to antiretroviral drugs by genotypic and recombinant virus phenotypic analyses"],"prefix":"10.1016","volume":"37","author":[{"given":"Shuai","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daomin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuoyi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2015.06.011_bib0135","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.cr.7290354","article-title":"The HIV epidemic in China: history, response, and challenge","volume":"15","author":"He","year":"2005","journal-title":"Cell Res"},{"key":"10.1016\/j.ijid.2015.06.011_bib0140","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/590945","article-title":"The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China","volume":"47","author":"Zhang","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.06.011_bib0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/135965350000500112","article-title":"The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan","volume":"5","author":"DeGruttola","year":"2000","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ijid.2015.06.011_bib0150","doi-asserted-by":"crossref","first-page":"e102258","DOI":"10.1371\/journal.pone.0102258","article-title":"HIV-1 pol diversity among female bar and hotel workers in northern Tanzania","volume":"9","author":"Kiwelu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2015.06.011_bib0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/375597","article-title":"Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society\u2013USA Panel","volume":"37","author":"Hirsch","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.06.011_bib0160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.antiviral.2006.05.003","article-title":"Algorithms for the interpretation of HIV-1 genotypic drug resistance information","volume":"71","author":"Vercauteren","year":"2006","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijid.2015.06.011_bib0165","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/dkg016","article-title":"Comparison of levels of HIV-1 resistance to protease inhibitors by recombinant versus conventional virus phenotypic assay and two genotypic interpretation procedures in treatment-na\u00efve and HAART-experienced HIV-infected patients","volume":"51","author":"Paolucci","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2015.06.011_bib0170","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/AAC.37.5.1095","volume":"37","author":"Japour","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.06.011_bib0175","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1128\/AAC.44.4.920-928.2000","article-title":"A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1","volume":"44","author":"Petropoulos","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.06.011_bib0180","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/AAC.42.2.269","article-title":"A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs","volume":"42","author":"Hertogs","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.06.011_bib0185","unstructured":"Los Alamos National laboratory, HIV Database. Available at: http:\/\/www.hiv.lanl.gov (accessed on August 8 2014)."},{"key":"10.1016\/j.ijid.2015.06.011_bib0190","unstructured":"Katholieke Universiteit Leuven, REGA HIV-1 & 2 Automated Subtyping Tool (Version 2.0). Available at: http:\/\/www.bioafrica.net\/rega-genotype\/html\/subtypinghiv.html (accessed on August 12 2014)."},{"key":"10.1016\/j.ijid.2015.06.011_bib0195","unstructured":"Stanford university, HIV drug resistance database Available at: http:\/\/hivdb.stanford.edu\/ (accessed on September 1 2014)."},{"key":"10.1016\/j.ijid.2015.06.011_bib0200","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1371\/journal.pmed.0020112","article-title":"Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration","volume":"2","author":"Kantor","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2015.06.011_bib0205","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/QAD.0b013e3282f29478","article-title":"Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase","volume":"22","author":"Kearney","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2015.06.011_bib0210","first-page":"637263","article-title":"Impact of novel resistance profiles in HIV-1 reverse transcriptase on phenotypic resistance to NVP","volume":"2012","author":"Jiao","year":"2012","journal-title":"AIDS Res Treat"},{"key":"10.1016\/j.ijid.2015.06.011_bib0215","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF03256421","article-title":"Phenotypic analysis of HIV-1 genotypic drug-resistant isolates from China, using a single-cycle system","volume":"15","author":"Jia","year":"2011","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.ijid.2015.06.011_bib0220","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1086\/510754","article-title":"Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infection","volume":"195","author":"Flandre","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2015.06.011_bib0225","doi-asserted-by":"crossref","first-page":"F41","DOI":"10.1097\/00002030-200210180-00002","article-title":"Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates","volume":"16","author":"Whitcomb","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2015.06.011_bib0230","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/QAD.0b013e328011e691","article-title":"HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance","volume":"21","author":"Shafer","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2015.06.011_bib0235","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.3390\/v6093535","article-title":"Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors","volume":"6","author":"Singh","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2015.06.011_bib0240","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/503914","article-title":"Web resources for HIV type 1 genotypic-resistance test interpretation","volume":"42","author":"Liu","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.06.011_bib0245","unstructured":"French National Agency for AIDS Research, HIV-1 genotypic drug resistance interpretation's algorithms. Available at: http:\/\/www.hivfrenchresistance.org\/2013\/Algo-sep-2013.pdf (accessed on September 1 2014)."},{"key":"10.1016\/j.ijid.2015.06.011_bib0250","unstructured":"Rega Institute for Medical Research and University Hospitals Leuven, Algorithm for the use of genotypic HIV-1 resistance data. Available at: http:\/\/rega.kuleuven.be\/cev\/avd\/files\/software\/rega_algorithm\/Rega_HIV1_Rules_v9.1.0.pdf (accessed on September 1 2014)."},{"key":"10.1016\/j.ijid.2015.06.011_bib0255","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1097\/00002030-200109070-00010","article-title":"World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing","volume":"15","author":"Harrigan","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2015.06.011_bib0260","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/AAC.48.2.437-443.2004","article-title":"Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1","volume":"48","author":"Parkin","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971215001459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971215001459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T05:36:57Z","timestamp":1652593017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971215001459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":26,"alternative-id":["S1201971215001459"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2015.06.011","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of susceptibility of HIV-1 variants to antiretroviral drugs by genotypic and recombinant virus phenotypic analyses","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2015.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}